Novartis is proudly at the forefront of ushering in the next chapter of healthcare innovation going beyond the traditional model of drug discovery through digital, data technology, and artificial intelligence.
We are at a critical and unique juncture, where science, technology and data are coming together in exciting new ways to help us not only develop new medicines and bring them to patients faster, but also to work smarter and more efficiently, deliver more meaningful experiences and ultimately achieve better health outcomes. AI offers tremendous potential to transform health systems from being reactive to proactive, predictive, and even preventive.
To help achieve our goal, we are committed to partnering with the technology world. This is critical to our approach and is why in 2020 we announced the expansion of the Novartis global network of digital innovation hubs, the Novartis Biome, to Canada.
The decision to expand to Canada and establish the Biome in Montreal is one that was made with ease thanks, in large part, to its thriving AI ecosystem, its status as a leading destination for talented researchers and companies in AI and access to the rich and vibrant technology community throughout Canada. We aim to draw on the many exciting digital health start-ups – or even just individuals with a great idea. Working in collaboration with health tech pioneers, who will become our partners, we will provide them access to the resources needed to develop their idea, test it and bring it to scale to create innovative solutions that can help enhance and accelerate the patient journey from diagnosis through treatment.
Joined by promising start-ups, together we will be reimagining the future of medicine through AI. The next chapter of healthcare innovation has arrived, and Novartis plans to take it to new heights.
